ADVISORY/OraSure Technologies to Host Media Briefing Following Blood Products Advisory Committee Meeting of the FDA; March 10th Committee Meeting to Address Proposed Studies to Support Approval of Over-the-Counter HIV Test Kits

--(BUSINESS WIRE)--OraSure Technologies, Inc. (NASDAQ:OSUR):

WHAT: OraSure Technologies, Inc. (NASDAQ:OSUR) CEO and President Douglas Michels will host an on-site media briefing following the Blood Products Advisory Committee (BPAC) meeting on March 10, 2006, to address the outcomes and next steps resulting from the BPAC discussion, as well as the potential for an OTC rapid HIV test from OraSure. The Company will be offering public comment at the BPAC meeting. The media briefing will include an open Q&A session for media, who may also participate via teleconference.

OraSure is the manufacturer of OraQuick(R) ADVANCE(TM), the first and only U.S. Food and Drug Administration approved and CLIA (Clinical Laboratory Improvements Amendments Act of 1988) waived rapid point-of-care test that can detect antibodies to both HIV-1 and HIV-2 in 20 minutes, using oral fluid, finger-stick or venipuncture whole blood or plasma specimens.

The BPAC meeting materials can be found at:
http://www.fda.gov/ohrms/dockets/ac/cber06.html

** CONFERENCE CALL LINE AVAILABLE FOR MEDIA NOT ATTENDING BPAC MEETING **

WHEN: March 10, 2006 BPAC Meeting: OTC segment scheduled for 8:30 AM - 12 PM Media Briefing: 1 - 1:30 PM

WHERE: Hilton Hotel, 620 Perry Parkway, Gaithersburg, MD, 20877
BPAC Meeting: Grand Ballroom, Lobby level
Media Briefing: Bethesda Room, Lobby level

DIAL-IN: Please contact Jennifer Moritz at 917-748-4006 or Erika Freed at 917-359-7974 to obtain dial-in information.

CONTACT: OraSure Technologies, Inc.
Media Contacts:
Zer0 to 5ive
Jennifer Moritz, 917-748-4006
jmoritz@0to5.com
or
Erika Freed, 917-359-7974
erika@0to5.com

SOURCE: OraSure Technologies, Inc.